15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Ibotta, Inc, 1 rate it Buy or better, 4 sit at Hold, and 2 rate it Sell or worse, a hold consensus. Targets range widely, $22.00 to $45.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $33.83 sits 23% above the current $27.41. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.38 next quarter toward $1.72 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Hold
Strong Buy00%
Buy114%
Hold457%
Sell229%
Strong Sell00%
Based on 7 analysts giving stock ratings to Ibotta, Inc.
As of Jul, 1 of 7 firms rate IBTA a Buy (4 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
IBTA EPS & revenue forecast
EPS · NEXT QUARTER
$0.38
Range $0.18 – $0.56 · 3 analysts · -33% YoY
Next period, 3 analysts expect Ibotta, Inc. to earn $0.38 a share (range $0.18 – $0.56), versus $0.56 a year earlier. Full-year consensus is $1.48, growing to $1.72 the year after.
REVENUE · NEXT QUARTER
$85.9M
Range $85.1M – $87.1M · 3 analysts · +3% YoY
Revenue is expected to reach $85.9M (range $85.1M – $87.1M), +3.2% year-over-year. Full-year consensus is $345.5M, rising to $376.7M next year.
Top analysts covering Ibotta, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IBTA.
#1
Eric Sheridan
Goldman Sachs · Rank #341
Sell
$28.00+2.2% to target
Overall win rate
32%
+ Follow
#2
Bernie McTernan
Needham · Rank #342
Buy
$45.00+64.2% to target
Overall win rate
27%
+ Follow
#3
Andrew Boone
JMP Securities · Rank #370
Hold
No targeton IBTA
Overall win rate
22%
+ Follow
#4
Ken Gawrelski
Wells Fargo
Hold
$38.00+38.6% to target
Coverage
—
+ Follow
#5
CK
Chris Kuntarich
UBS
Hold
$30.00+9.4% to target
Coverage
—
+ Follow
IBTA stock forecast FAQ
What is IBTA's average 12-month price target?+
The 6 analysts with a live target average $33.83 for Ibotta, Inc. over the next 12 months, ranging from a $45.00 high to a $22.00 low.
Is IBTA stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 7 analyst ratings, 1 are Buy or Strong Buy, 4 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for IBTA?+
The Street-high target is $45.00 (Needham), and the Street-low is $22.00 (B of A Securities). The average of all 6 active targets is $33.83.
How many Wall Street analysts cover IBTA?+
7 analysts have an active rating on Ibotta, Inc., and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering IBTA?+
Among analysts who currently cover IBTA, Eric Sheridan of Goldman Sachs has the strongest overall Quantellect track record (Rank #341). Their current call is Sell with a $28.00 target.
What is Ibotta, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.38 per share (range $0.18 – $0.56) across 3 analysts. Full-year EPS is projected at $1.48, rising to $1.72 the following year.
How much revenue is Ibotta, Inc. expected to report next quarter?+
Consensus revenue is $85.9M (range $85.1M – $87.1M). Full-year revenue is projected at $345.5M, growing to $376.7M next year.
Have analysts been upgrading or downgrading IBTA lately?+
As of Jul, 1 of 7 firms rate IBTA a Buy (4 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IBTA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
